ArticleJournal of neuro-oncology2019

Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.

Shuyu Hao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.